NSC |
Compound |
Enrichment |
Correlation |
NSC 686362 |
Null |
0.011544784012433 |
0.56902492 |
NSC 693142 |
Null |
0.011544784012433 |
0.080020592 |
NSC 713019 |
Null |
0.011544784012433 |
0.17809827 |
NSC 730632 |
{6-(3-Amino-1-propyl)-5,6-dihydro-2,3-dimethoxy-8,9-methylen edioxy-5,11-dioxo-11H-indeno[1,2-c]-isoquinoline}-{5',6'-Dih ydro-6'-(3'-amino-1'-propyl)-5',11'-dioxo-11'H-indeno[1,2-c] -isoquinoline}pr |
0.011544784012433 |
0.51648876 |
NSC 730946 |
4-(2-(4-methoxyphenyl)ethynyl)-3-(3,4,5-trimethoxyphenyl)fur an-2(5H)-one |
0.011544784012433 |
0.25941315 |
NSC 740644 |
6-(3-Bromopropyl)-9-ethoxy-5,6-dihydro-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.011544784012433 |
0.1319594 |
NSC 743264 |
Null |
0.011544784012433 |
0.19587084 |
NSC 744116 |
Null |
0.011544784012433 |
0.30331931 |
NSC 750148 |
3-(2-Hydroxy-5-chloro-4-methylphenyl)-5-(2-phenylethene)-1-(4-sulfamylphenyl)-pyrazoline |
0.011544784012433 |
0.17048584 |
NSC 140380 |
Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) |
0.0115447840124334 |
0.44902916 |